Target intelligence / Profile preview

Tear film viscosity (TFV)

Target
TFV
Molecular classification
Other
01

Overview

Tear film viscosity refers to the physical property describing the resistance of the tear fluid to flow. It is not a molecule, receptor, enzyme, or protein but rather a measurable characteristic of the entire tear film—a complex mixture composed mainly of water, proteins (such as mucins and lysozyme), lipids, and electrolytes. The optimal viscosity is crucial for ocular health; low viscosity during blinking prevents damage to epithelial surfaces by allowing easy shear movement, while higher viscosity when the eye is open helps maintain a stable tear layer and resists drainage or break-up[1][3]. Abnormalities in tear film viscosity are associated with dry eye diseases such as Sjögren syndrome; lower TFV indices have been shown to distinguish between different types of dry eye disease[5]. Artificial tears are formulated with varying viscosities to supplement natural tears in patients with deficient or abnormal tear films. However, excessively viscous artificial tears may cause visual disturbances or discomfort—especially for contact lens users—highlighting the need for balanced rheological properties in therapeutic products[7]. **Note:** "Tear film viscosity" is not itself a molecular target but rather a biophysical property resulting from interactions among multiple molecular components within the tear film. Therefore, it should not be classified as a canonical drug target such as an enzyme or receptor.

02

Mechanism of action

Increase or modulate tear film viscosity to improve lubrication and reduce evaporation[3][5]

03

Biological functions

Lubrication of ocular surfaceMaintenance of tear film stabilityProtection against epithelial damage
04

Disease associations

Dry eye disease (DED)
05

Safety considerations

Excessively high viscosity can impair vision or cause discomfort, especially for contact lens wearers[7]
06

Interacting drugs

Artificial tears (various formulations)
07

Biomarkers

Momentary moving speed (MMS) indices, α and β parameters from power-law fitting in TFV analysis[5]

Beyond the preview

Go deeper on Tear film viscosity (TFV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tear film viscosity (TFV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call